Brief: Acer Therapeutics And Relief Therapeutics Announce That The China National Intellectual Property Administration Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form
08/07/2022 13:38
July 8 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE THAT
THE
CHINA NATIONAL INTELLECTUAL PROPERTY ADMINISTRATION (CNIPA)
ISSUED UTILITY MODEL PATENT 11,202,767 COVERING ACER-001 DOSAGE
FORM
* ACER THERAPEUTICS INC - NEWLY ISSUED PATENT HAS AN
EXPIRATION
DATE OF AUGUST 24, 2031
Source text for Eikon: ID:nGNX3SvNCc
Further company coverage: ACER.O
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31